Carmell Therapeutics Corporation (CTCX) Earning

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$0
Day's range
$0

Earnings History by Quarter

Date Quarter Consensus Estimate Reported EPS Beat/Miss Revenue Estimate Actual Revenue
03/31/2026 Q4 2025 N/A -$2.37 N/A N/A $472.98 K
11/14/2025 Q3 2025 N/A -$0.83 N/A N/A $425.86 K
08/14/2025 Q2 2025 N/A -$1.56 N/A N/A $503.61 K
05/15/2025 Q1 2025 N/A -$0.07 N/A N/A $510.35 K
03/31/2025 Q4 2024 N/A -$0.04 N/A N/A $17.48 K
11/14/2024 Q3 2024 N/A -$0.14 N/A N/A $20.52 K
08/14/2024 Q2 2024 N/A -$0.16 N/A N/A $12.32 K
03/29/2024 Q1 2024 N/A -$0.21 N/A N/A $0
12/30/2023 Q4 2023 N/A $0.15 N/A N/A $-3,728,816
09/29/2023 Q3 2023 N/A -$0.62 N/A N/A $3.73 M
06/29/2023 Q2 2023 N/A $0.02 N/A N/A $0
03/29/2023 Q1 2023 N/A $0.03 N/A N/A $0
12/30/2022 Q4 2022 N/A -$0.16 N/A N/A $0
11/10/2022 Q3 2022 N/A -$0.32 N/A N/A $0
08/10/2022 Q2 2022 N/A -$0.02 N/A N/A $0
05/20/2022 Q1 2022 N/A -$0.03 N/A N/A $0
04/15/2022 Q4 2021 N/A -$0.01 N/A N/A $0
11/22/2021 Q3 2021 N/A -$0.00 N/A N/A $0
09/13/2021 Q2 2021 N/A -$0.00 N/A N/A $0

Earnings: FAQ's

The conference call for 's latest earnings report can be listened to online.

The conference call transcript for 's latest earnings report can be read online.

(:CTCX) has a recorded annual revenue of $1.91 M.

(:CTCX) has a recorded net income of $-6,905,282. has generated $-4.83 earnings per share over the last four quarters.

(:CTCX) has a price-to-earnings ratio of -0.08 and price/earnings-to-growth ratio is 0.

Portfolio Sync
Solutions

Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced

GET STARTED